Gale Scott

Gorsuch on SCOTUS: likely to influence many health policies.

Breakthrough status for a new drug to treat familial hypercholesterolemia.

A drug to help Huntington's symptoms got the FDA's nod.

Physicians have more choices than guidance in picking diabetes drugs.

Medicine can be exhausting.Tips on avoiding burnout.

Indwelling catheters are over-used, expert says.

Can anything halt runaway drug prices? ACP asks.

Noted rheumatologist reviews research.

The Affordable Care Act is still under attack, according to the ACP.

Hepatitis C care often doesn't require a specialist.

Physicians can play a role in curbing substance misuse.

NIAID's director announced progress in developing a Zika vaccine.

Diets high in sugar and saturated fat are associated with ADHD.

THe ACC's meeting offered studies likelcc200y to impact clinical practice.

Nektar Therapeutics announced favorable phase 3 results for NKTR-181.

Heart damage after non-cardiac surgery is usually missed. A test finds it.

In patients with AFib, digoxin should not be a first-line drug.

Microbleeds in the brain appear to increase with cardiac procedures:Study.

In the first head to head trial, rivaroxaban was more effective than aspirin.

A synthetic version of "good" cholesterol failed to clear blocked arteries.

Bleeding complications with rivaroxaban no worse than with aspirin.

Study: no worries about cognition loss with PCSK9s.

The Absorb GT1 Bioresorbable Vascular Stent raised concerns at the FDA.

Drugs were as effective in CTO patients as PCI, Korean study found.

New diagnostic tool iFR is less painful for heart patients than FFR.

In a large, long-term clinical trial evolocumab reduced heart risk.

In another major study comparing TAVR to surgery, outcomes were similar.

Mishaps show stem cell clinics need regulation, journal says.

Details on why Pfizer pulled its PCSK9 inhibitor seen in SPIRE studies.

A panel wants the FDA to restrict an opioid because abusers are injecting it.